Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by National Cancer Center, Korea.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT00453323
First received: March 27, 2007
Last updated: July 9, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
No publications provided by National Cancer Center, Korea

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):